Clinical Trial Update: Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous mesenchymal bone marrow stem cells in active and progressive multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Autologous mesenchymal bone marrow stem cells

Snippet

Sponsor: Dimitrios Karussis | Conditions: Multiple Sclerosis (MS) | Phase 2 | Status: COMPLETED